Study S001113

Adiponectin and Its Role in the Treatment of Patients With Metabolic Disorders

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07539584
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 130
Start: 2022-03-01
Primary completion: 2024-04-08
Lead sponsor: Moscow Regional Research and Clinical Institute (MONIKI)
Conditions: Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD); Type 2 Diabetes Mellitus (T2DM)
Interventions: DRUG:SGLT2 inhibitor; DRUG:GLP-1 RA
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in serum HMW-adiponectin levels [Baseline and 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.